Abstract
In daily haematological practice, predicting bleeding in thrombocytopenic patients is difficult, and clinicians adhere to transfusion triggers to guide patients through the aplastic phase of chemotherapy. Platelet count is not the only determinant of bleeding and additional mechanisms for impending haemostasis are likely. Beside clot formation, platelets are essential for the maintenance of integrity of vascular beds. We therefore prospectively investigated associations between biomarkers for endothelial damage (urine albumin excretion) and inflammation (C-reactive protein) and bleeding (WHO grading) in 88 patients with 116 on-protocol episodes. We found an increase in grade 2 bleeding with a higher urine albumin/creatinine ratio one day after the measurement [odds ratio (OR) 1 center dot 24 for every doubling of the ratio, 95% CI 1 center dot 05-1 center dot 46, P-value 0 center dot 01] and a 29% increase in the odds of grade 2 bleeding for every doubling of serum C-reactive protein (CRP) (95% CI 1 center dot 04-1 center dot 60, P-value 0 center dot 02) after correction for morning platelet count. The 24 h post-transfusion corrected count increment (CCI24) showed a significant association with these biomarkers: increasing urine albumin/creatinine ratio and CRP were associated with lower CCI24. We report two inexpensive and easy-to-apply biomarkers that could be useful in designing a prediction model for bleeding risk in thrombocytopenic patients.
Original language | English |
---|---|
Pages (from-to) | 171-181 |
Number of pages | 11 |
Journal | British Journal of Haematology |
Volume | 189 |
Issue number | 1 |
Early online date | 15 Nov 2019 |
DOIs | |
Publication status | Published - Apr 2020 |
Keywords
- haemorrhage
- platelet transfusion
- thrombocytopenia
- microalbuminuria
- CRP
- C-REACTIVE PROTEIN
- PLATELET-TRANSFUSION
- HEMATOLOGICAL MALIGNANCIES
- RISK
- MICROALBUMINURIA